<DOC>
	<DOCNO>NCT01874015</DOCNO>
	<brief_summary>This study prospective , randomize , parallel , phase 1 trial ass safety feasibility transplantation bone marrow derive mesenchymal stem cell ( MSCs ) fistulizing Crohn 's disease .</brief_summary>
	<brief_title>Transplantation Bone Marrow Mesenchymal Stem Cell Crohn 's Disease</brief_title>
	<detailed_description>In study eligible patient randomly allocate two study group permute block randomization method : group A receive autologous MSCs suspend fibrin glue , group B receive autologous MSCs+ Fibroblasts . Both group receive 4 injection inside wall lumen fistula . Injections repeat every month .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1 Poor response routine treatment refractory Crohn 's disease fistula . 2 CDAI &gt; 220 3 Age 18 60 year 4 GFR &gt; 30 , Cr &lt; 2 5 The presence perineum fistula . pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>fistula</keyword>
</DOC>